	Re: Contieri R, Paciotti M, Uleri A, et al. Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol. 2026;9:404-412. Eur Urol Oncol Scarpa RM. PMID: 42624768 [PubMed - as supplied by publisher]
	Preliminary clinical outcomes of accelerator-based BNCT for head and neck cancer. Auris Nasus Larynx Aihara T, Higashino M, Takeno S, Hu N, Nihei K, Kawata R, Ono K. PMID: 42624745 [PubMed - as supplied by publisher]
	PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study. J Nucl Med Jafarvand M, Farolfi A, Mei R, Djaileb L, Benz M, Chung A, Brisbane W, Marks L, Grogan T, Gafita A, Theus L, Nguyen AT, Czernin J, Calais J. PMID: 42624652 [PubMed - as supplied by publisher]
	Bilateral optic neuropathy secondary to chronic lymphocytic leukaemia infiltration. BMJ Case Rep Lobo V, Monteiro B, Rebocho Duarte S, Tavares Ferreira J. PMID: 42624629 [PubMed - indexed for MEDLINE]
	Management of solitary fibrous tumour in the head and neck region: clinical and surgical considerations. BMJ Case Rep Martínez Moreno M, Dinu Pistolea R, Guallart Domenech F, Pons Rocher F. PMID: 42624627 [PubMed - indexed for MEDLINE]
	Long-term cancer risk after metal-on-metal hip arthroplasty: a Finnish population-based study with a mean follow-up of 12.8 years. BMJ Open Autio E, Vahlberg T, Ekman E, Laaksonen I, Hemmilä M, Eskelinen A, Mäkelä K. PMID: 42624603 [PubMed - indexed for MEDLINE]
	Artificial intelligence-driven prediction of neoadjuvant chemotherapy response in adult patients with gastric cancer: a systematic review and meta-analysis. BMJ Open Deng Y, Bao A, Wang H. PMID: 42624598 [PubMed - indexed for MEDLINE]
	Multicentre randomised controlled trial of a nurse-led family intervention on post-traumatic stress symptoms in families of children with cancer in China: protocol for the SCCIP-N trial. BMJ Open Zeng X, Kong Y, Shi Y, Ye Y, Gu C. PMID: 42624591 [PubMed - indexed for MEDLINE]
	The emerging trends in prostate cancer treatment: a systematic review of the literature. J Chemother Fatima SA, Haider KH, Qutubuddin S, Begum Y, Stevenson M, Fatima K, Anwar EI, Barg M. PMID: 42624527 [PubMed - as supplied by publisher]
	The molecular mechanisms and therapeutic targeting of microtubule glutamylation in mitosis and cancer. Pharmacol Ther Li K, Sun S. PMID: 42624259 [PubMed - as supplied by publisher]
	Highly Accurate Detection of Circulating Tumor DNA for Monitoring Minimal Residual Disease in Solid Tumors: Analytical and Clinical Validation of the Haystack MRD Assay. J Mol Diagn Clark M, Prathapam R, Bramlett KS, Helfrich-Kröger A, Sussman RT, Hwang HJ, Querfurth R, Champion KJ, Holtrup F, Slavin TP, Küntzlin-Schierloh D, Koenig A, Frame IJ, Maramica I, Quinn H, Kaplan JB, Mehnert DH, Sass C, Cleveland CL, Elzinga C, DeGrazia J, Angeloni T, Goos-Root D, Powers S, Carbonell JI, Stirzaker R, Debrincat MA, Chapman M, Brown E, Ryder M, Gibbs P, Sloane HS, Edelstein D, Tie J. PMID: 42624249 [PubMed - as supplied by publisher]
	Diagnostic Performance of a Multiplex Circulating Tumor DNA Assay for Lung Cancer Detection. J Mol Diagn Hjorth-Hansen P, Jacobsen CM, Nederby L, Borg M, Hilberg O, Wen SWC, Timm S, Hansen TF, Andersen RF. PMID: 42624248 [PubMed - as supplied by publisher]
	Numerical study of the optimization of theranostic performance of (Au/SiOâ‚‚/Au) spherical gold nanomatryoshkas for cervical cancer through structural tuning: Comparative analysis in healthy and infected tissues. Nanomedicine Abich K, Masrour R, Akouibaa A, Benhamou M. PMID: 42624187 [PubMed - as supplied by publisher]
	How reliable is pathological complete response (pCR) as an endpoint in rectal cancer clinical trials. Crit Rev Oncol Hematol Kundu S, Basu A, Das S, Kundu S. PMID: 42624181 [PubMed - as supplied by publisher]
	KDM4A-Driven Epigenetic Reprogramming as a Central Nexus Linking Metabolic Adaptation, Immune Remodeling, and Therapy Resistance in Cancer. Crit Rev Oncol Hematol Tang X, Zhao Y, Yang X, Cheng J. PMID: 42624180 [PubMed - as supplied by publisher]
	Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial. Lancet Sun HC, Zhu XD, Shen F, Song TQ, Bai XL, Zeng YY, Chen MS, Huang ZY, Cai JQ, Gao J, Kuang M, Li DY, Xing BC, Li XC, Wen TF, Peng T, Wang YD, Liu LX, Huang C, Shi YH, Huang XW, Wang K, Gao Q, Zhou J, Fan J. PMID: 42624156 [PubMed - indexed for MEDLINE]
	Adjunctive ultrasonography in breast cancer screening: the J-START trial - Authors' reply. Lancet Harada-Shoji N, Suzuki A, Ishida T, Yamamoto S, Ohuchi N. PMID: 42624151 [PubMed - in process]
	Adjunctive ultrasonography in breast cancer screening: the J-START trial. Lancet Fushimi A. PMID: 42624150 [PubMed - in process]
	Adjunctive ultrasonography in breast cancer screening: the J-START trial. Lancet Jing S, Song J. PMID: 42624149 [PubMed - in process]
	Adjunctive ultrasonography in breast cancer screening: the J-START trial. Lancet Macios A, Bretthauer M, Kalager M. PMID: 42624148 [PubMed - in process]

Articles 1 - 20 / 1965500

Page 1 of 98275



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy